63 related articles for article (PubMed ID: 15958578)
41. Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy.
Friedman GK; Raborn J; Kelly VM; Cassady KA; Markert JM; Gillespie GY
Front Oncol; 2013; 3():28. PubMed ID: 23450706
[TBL] [Abstract][Full Text] [Related]
42. The roles of viruses in brain tumor initiation and oncomodulation.
Kofman A; Marcinkiewicz L; Dupart E; Lyshchev A; Martynov B; Ryndin A; Kotelevskaya E; Brown J; Schiff D; Abounader R
J Neurooncol; 2011 Dec; 105(3):451-66. PubMed ID: 21720806
[TBL] [Abstract][Full Text] [Related]
43. Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1.
Advani SJ; Markert JM; Sood RF; Samuel S; Gillespie GY; Shao MY; Roizman B; Weichselbaum RR
Gene Ther; 2011 Nov; 18(11):1098-102. PubMed ID: 21544094
[TBL] [Abstract][Full Text] [Related]
44. A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses.
Lilley CE; Chaurushiya MS; Boutell C; Landry S; Suh J; Panier S; Everett RD; Stewart GS; Durocher D; Weitzman MD
EMBO J; 2010 Mar; 29(5):943-55. PubMed ID: 20075863
[TBL] [Abstract][Full Text] [Related]
45. Chromatin at the intersection of viral infection and DNA damage.
Lilley CE; Chaurushiya MS; Weitzman MD
Biochim Biophys Acta; 2010; 1799(3-4):319-27. PubMed ID: 19616655
[TBL] [Abstract][Full Text] [Related]
46. Viral manipulation of DNA repair and cell cycle checkpoints.
Chaurushiya MS; Weitzman MD
DNA Repair (Amst); 2009 Sep; 8(9):1166-76. PubMed ID: 19473887
[TBL] [Abstract][Full Text] [Related]
47. ICP0 inhibits the decrease of HSV amplicon-mediated transgene expression.
Suzuki M; Kasai K; Ohtsuki A; Godlewski J; Nowicki MO; Chiocca EA; Saeki Y
Mol Ther; 2009 Apr; 17(4):707-15. PubMed ID: 19223864
[TBL] [Abstract][Full Text] [Related]
48. Low-dose hypersensitivity: current status and possible mechanisms.
Joiner MC; Marples B; Lambin P; Short SC; Turesson I
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):379-89. PubMed ID: 11173131
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of DNA repair by a herpes simplex virus vector enhances the radiosensitivity of human glioblastoma cells.
Hadjipanayis CG; DeLuca NA
Cancer Res; 2005 Jun; 65(12):5310-6. PubMed ID: 15958578
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic efficacy of a herpes simplex virus with radiation or temozolomide for intracranial glioblastoma after convection-enhanced delivery.
Hadjipanayis CG; Fellows-Mayle W; Deluca NA
Mol Ther; 2008 Nov; 16(11):1783-8. PubMed ID: 18728637
[TBL] [Abstract][Full Text] [Related]
51. Attenuation of DNA-dependent protein kinase activity and its catalytic subunit by the herpes simplex virus type 1 transactivator ICP0.
Lees-Miller SP; Long MC; Kilvert MA; Lam V; Rice SA; Spencer CA
J Virol; 1996 Nov; 70(11):7471-7. PubMed ID: 8892865
[TBL] [Abstract][Full Text] [Related]
52. Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.
Maachani UB; Kramp T; Hanson R; Zhao S; Celiku O; Shankavaram U; Colombo R; Caplen NJ; Camphausen K; Tandle A
Mol Cancer Res; 2015 May; 13(5):852-62. PubMed ID: 25722303
[TBL] [Abstract][Full Text] [Related]
53. Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma.
Reichert S; Rödel C; Mirsch J; Harter PN; Tomicic MT; Mittelbronn M; Kaina B; Rödel F
Radiother Oncol; 2011 Oct; 101(1):51-8. PubMed ID: 21852011
[TBL] [Abstract][Full Text] [Related]
54. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta.
Härle P; Sainz B; Carr DJ; Halford WP
Virology; 2002 Feb; 293(2):295-304. PubMed ID: 11886249
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
